| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Profit before tax | 5.0 | 0.6 |
| Net income | 5.0 | 0.4 |
| EPS (diluted, $ a share) | $-0.29 | $11.59 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | +1072.3% |
|---|
10-Q filed with the SEC, NASDAQ: NXTS. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Nexentis Technologies Inc.: key numbers
- Share price
- $1.99Close, Nov 16
- Market cap
- $1.33M
- Shares outstanding
- 666.66KLatest SEC cover page
- Sector
- Life Sciences
- Industry
- Pharmaceutical PreparationsSIC 2834
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Nexentis Technologies Inc.
All →Nexentis Technologies Business Update
Nexentis Technologies Inc. issued 72,000 shares of common stock to consultants on November 9, 2026. The shares were issued as payment for various investor relations and business development services provided to the company. The transaction was conducted as a private placement exempt from registration under Section 4(a)(2) of the Securities Act.
Nexentis Technologies Reverse Stock Split
Nexentis Technologies Inc. implemented a 1-for-5 reverse stock split of its common stock, effective November 6, 2026. The split is intended to increase the per-share bid price to regain compliance with Nasdaq's continued listing requirements. The total number of outstanding shares will be reduced from approximately 2.9 million to approximately 600,000.
Nexentis Technologies Stock Plan Amendment
Nexentis Technologies issued an aggregate of 361,188 shares of common stock to its CEO, CFO, and directors under its 2022 Share Incentive Plan. Additionally, the company issued 561,000 shares to various consultants for accounting, financial, and investor relations services. These equity grants serve as compensation for services rendered and were issued as unregistered sales of equity securities.
Nexentis Technologies Nasdaq/NYSE Compliance Notice
Nexentis Technologies amended several series of outstanding warrants to remove liability classification provisions and reclassify them as equity for accounting purposes. This action was taken specifically to help the company regain compliance with Nasdaq Listing Rule 5550(b)(1), which relates to minimum stockholders' equity requirements. The amendments do not change the exercise price, share count, or expiration dates of the warrants.
- Counterparty
- Nasdaq